Regulatory T cell is critical for interleukin-33-mediated neuroprotection against stroke

[1]  T. S. Kim,et al.  IL-33 changes CD25hiTregs to Th17 cells through a dendritic cell-mediated pathway. , 2019, Immunology letters.

[2]  W. Xiao,et al.  The role of Interleukin-33 in the modulation of splenic T-cell immune responses after experimental ischemic stroke , 2019, Journal of Neuroimmunology.

[3]  A. Uzdensky.  Apoptosis regulation in the penumbra after ischemic stroke: expression of pro- and antiapoptotic proteins , 2019, Apoptosis.

[4]  P. Carmeliet,et al.  Functional Reprogramming of Regulatory T cells in the absence of Foxp3 , 2019, Nature Immunology.

[5]  J. Buer,et al.  The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer , 2019, Mucosal Immunology.

[6]  Osamu Yoshie,et al.  Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery , 2019, Nature.

[7]  Adan Chari Jirmo,et al.  Absence of Regulatory T Cells Causes Phenotypic and Functional Switch in Murine Peritoneal Macrophages , 2018, Front. Immunol..

[8]  S. Nakae,et al.  Interleukin-33 Protects Ischemic Brain Injury by Regulating Specific Microglial Activities , 2018, Neuroscience.

[9]  M. Kameda,et al.  Electrical Stimulation Enhances Migratory Ability of Transplanted Bone Marrow Stromal Cells in a Rodent Ischemic Stroke Model , 2018, Cellular Physiology and Biochemistry.

[10]  Wei Zhang,et al.  Reciprocal Expression of IL-35 and IL-10 Defines Two Distinct Effector Treg Subsets that Are Required for Maintenance of Immune Tolerance. , 2017, Cell reports.

[11]  R. Leak,et al.  ST2/IL-33-Dependent Microglial Response Limits Acute Ischemic Brain Injury , 2017, The Journal of Neuroscience.

[12]  P. Jiao,et al.  Oxidized high density lipoprotein induces macrophage apoptosis via toll-like receptor 4-dependent CHOP pathway[S] , 2016, Journal of Lipid Research.

[13]  C. Kessler,et al.  Reduced Numbers and Impaired Function of Regulatory T Cells in Peripheral Blood of Ischemic Stroke Patients , 2016, Mediators of inflammation.

[14]  Jinfang Zhu,et al.  Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells. , 2015, Cytokine.

[15]  J. Montaner,et al.  Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation , 2015, Brain, Behavior, and Immunity.

[16]  Ji-xian Wang,et al.  Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10 , 2015, Front. Cell. Neurosci..

[17]  A. Rudensky,et al.  A Distinct Function of Regulatory T Cells in Tissue Protection , 2015, Cell.

[18]  R. Locksley,et al.  Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. , 2015, Immunity.

[19]  C. Helmstetter,et al.  T-bet– and STAT4–dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses , 2015, Proceedings of the National Academy of Sciences.

[20]  James T. Walsh,et al.  The Glia-Derived Alarmin IL-33 Orchestrates the Immune Response and Promotes Recovery following CNS Injury , 2015, Neuron.

[21]  Zhihui Liang,et al.  Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response , 2015, Brain Research.

[22]  J. Koistinaho,et al.  Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury , 2015, Brain, Behavior, and Immunity.

[23]  H. Turnquist,et al.  IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells To Selectively Expand IL-33R/ST2+ Regulatory T Cells , 2014, The Journal of Immunology.

[24]  Yasmine Belkaid,et al.  The Alarmin IL-33 Promotes Regulatory T Cell Function in the Intestine , 2014, Nature.

[25]  C. Benoist,et al.  A Special Population of Regulatory T Cells Potentiates Muscle Repair , 2013, Cell.

[26]  C. Benoist,et al.  Regulatory T cells in nonlymphoid tissues , 2013, Nature Immunology.

[27]  Jun Chen,et al.  Adoptive regulatory T‐cell therapy protects against cerebral ischemia , 2013, Annals of neurology.

[28]  G. Keren,et al.  Interleukin-33 augments Treg cell levels: a flaw mechanism in atherosclerosis. , 2012, The Israel Medical Association journal : IMAJ.

[29]  Daniel J. Kuster,et al.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo , 2012, The Journal of experimental medicine.

[30]  P. Zhu,et al.  Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/Foxp3+ Regulatory T-Cell Responses in Mice , 2012, Molecular medicine.

[31]  Y. Setiady,et al.  In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti‐CD25 monoclonal antibody is mediated by FcγRIII+ phagocytes , 2010, European journal of immunology.

[32]  G. V. Chaitanya,et al.  Granzyme-b is involved in mediating post-ischemic neuronal death during focal cerebral ischemia in rat model , 2010, Neuroscience.

[33]  D. Vignali,et al.  Regulatory T cells and inhibitory cytokines in autoimmunity. , 2009, Current opinion in immunology.

[34]  N. Arsenijević,et al.  Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin. , 2009, Molecular immunology.

[35]  J. Myśliwska,et al.  Ex vivo expansion of CD4+CD25+ T regulatory cells for immunosuppressive therapy , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[36]  C. Sommer,et al.  Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke , 2009, Nature Medicine.

[37]  J. Pandian,et al.  Immune activation in the peripheral blood of patients with acute ischemic stroke , 2009, Journal of Neuroimmunology.

[38]  D. D. Di Monte,et al.  Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease1 , 2008, The Journal of Immunology.

[39]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[40]  A. Vandenbark,et al.  T- and B-Cell-Deficient Mice with Experimental Stroke have Reduced Lesion Size and Inflammation , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  J. Toutain,et al.  Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse , 2007, Experimental Neurology.

[42]  B. Bäckström,et al.  Partial Depletion of CD69low‐expressing Natural Regulatory T Cells with the Anti‐CD25 Monoclonal Antibody PC61 , 2007, Scandinavian journal of immunology.

[43]  Á. Chamorro,et al.  Signalling pathways mediating inflammatory responses in brain ischaemia. , 2006, Biochemical Society transactions.

[44]  Shimon Sakaguchi,et al.  Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease , 2006, Immunological reviews.

[45]  E. Suri‐Payer,et al.  Regulatory T cells in experimental autoimmune disease , 2006, Springer Seminars in Immunopathology.

[46]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[47]  D. Granger,et al.  Role of T Lymphocytes and Interferon-γ in Ischemic Stroke , 2006 .

[48]  L. Chess,et al.  Regulation of immune responses by T cells. , 2006, The New England journal of medicine.

[49]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[50]  L. A. Stephens,et al.  Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System1 , 2005, The Journal of Immunology.

[51]  M. Moskowitz,et al.  Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke , 2005, Journal of the Neurological Sciences.

[52]  A. Rudensky,et al.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.

[53]  S. Ibayashi,et al.  Postischemic Gene Transfer of Interleukin-10 Protects Against Both Focal and Global Brain Ischemia , 2005, Circulation.

[54]  A. O’Garra,et al.  IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. , 2004, The Journal of clinical investigation.

[55]  R. Dantzer,et al.  Interleukin-10 in the brain. , 2001, Critical reviews in immunology.

[56]  E. Ongini,et al.  Interleukin‐10 modulates neuronal threshold of vulnerability to ischaemic damage , 2000, The European journal of neuroscience.

[57]  J. Ellison,et al.  IL-10 reduces rat brain injury following focal stroke , 1998, Neuroscience Letters.

[58]  K. Becker,et al.  Experimental & Translational Stroke Medicine Long Term Immunologic Consequences of Experimental Stroke and Mucosal Tolerance , 2009 .

[59]  S. Jander,et al.  T-cell cytokines in injury-induced neural damage and repair , 2007, NeuroMolecular Medicine.